S-CELLERATE Trademark

Trademark Overview


On Tuesday, January 25, 2022, a trademark application was filed for S-CELLERATE with the United States Patent and Trademark Office. The USPTO has given the S-CELLERATE trademark a serial number of 79339661. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 18, 2024. This trademark is owned by Samsung Biologics Co., Ltd.. The S-CELLERATE trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of biopharmaceutical materials with generation of cell line; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals

Medical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; research of medical products; bacteriological research and analysis; medical laboratory services; stem cell research services; scientific research in the nature of conducting clinical trials; medicine research; research and development of technology for biotechnology; microbial testing for scientific research purposes; biochemistry research services; scientific research in the field of genetics; scientific research in the field of genetic engineering
s-cellerate

General Information


Serial Number79339661
Word MarkS-CELLERATE
Filing DateTuesday, January 25, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Goods and ServicesCustom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of biopharmaceutical materials with generation of cell line; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals
Goods and ServicesMedical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; research of medical products; bacteriological research and analysis; medical laboratory services; stem cell research services; scientific research in the nature of conducting clinical trials; medicine research; research and development of technology for biotechnology; microbial testing for scientific research purposes; biochemistry research services; scientific research in the field of genetics; scientific research in the field of genetic engineering

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Biologics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSamsung Biologics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, May 10, 2022APPLICATION FILING RECEIPT MAILED
Thursday, May 5, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, July 10, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, October 6, 2022CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, November 4, 2022ASSIGNED TO EXAMINER
Wednesday, November 16, 2022NON-FINAL ACTION WRITTEN
Thursday, November 17, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 23, 2023REFUSAL PROCESSED BY MPU
Monday, January 23, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Wednesday, June 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, June 11, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, June 11, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, January 1, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Monday, July 1, 2024NOTIFICATION PROCESSED BY IB
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED